Telmisartan induces apoptosis and regulates Bcl-2 in human renal cancer cells

Experimental Biology and Medicine

Volumn 240, Issue 1, 2015, Pages 34-44

  de Araújo Júnior, Raimundo Fernandes ^a   Leitão Oliveira, Ana Luiza CS ^a   de Melo Silveira, Raniere Fagundes ^a   de Oliveira Rocha, Hugo Alexandre ^a   de França Cavalcanti, Pedro ^b   de Araújo, Aurigena Antunes ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^b Institute of Neuroscience of Natal   (Brazil)

Author keywords

apoptosis; Bcl 2; caspase 3; human cancer cells; Telmisartan

Indexed keywords

CASPASE 3; CISPLATIN; LIPOCORTIN 5; PROPIDIUM IODIDE; PROTEIN BCL 2; TELMISARTAN; ANTINEOPLASTIC AGENT; BENZIMIDAZOLE DERIVATIVE; BENZOIC ACID DERIVATIVE;

APOPTOSIS; APOPTOSIS ASSAY; ARTERIAL PRESSURE; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; KIDNEY CANCER; MTT ASSAY; PROPIDIUM IODIDE ASSAY; RENAL CANCER CELL LINE; RENAL CELL CARCINOMA CELL LINE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ANTAGONISTS AND INHIBITORS; CELL SURVIVAL; DRUG EFFECTS; KIDNEY TUMOR; METABOLISM; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZIMIDAZOLES; BENZOATES; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 84920973206     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370214546267     Document Type: Article

References (37)

1. Sourbier C,Massfelder T.Parathyroid hormone-related protein in human renal cell carcinoma.Cancer Lett. 2006;240 (2): 170-82
2. Schrader AJ,Varga Z,Hegele A,Pfoertner S,Olbert P,Hofmann R.Second-line strategies for metastatic renal cell carcinoma: Classics and novel approaches.J Cancer Res Clin Oncol. 2006;132 (3): 137-49
3. Tolle A,Jung M,Lein M,Johannsen M,Miller K,Moch H,Jung K,Kristiansen G.Brain-type and liver-type fatty acid-binding proteins: New tumor markers for renal cancer?.BMC Cancer. 2009;9:248-248
4. Escudier B.Advanced renal cell carcinoma: Current and emerging management strategies.Drugs. 2007;67 (9): 1257-64
5. Kosugi M,Miyajima A,Kikuchi E,Horiguchi Y,Murai M.Angiotensin II type 1 receptor antagonist candesartan as an angiogenic inhibitor in a xenograft model of bladder cancer.Clin Cancer Res. 2006;12 (9): 2888-93
6. Fujimoto Y,Sasaki T,Tsuchida A,Chayama K.Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist.FEBS Lett. 2001;495 (3): 197-200
7. Amaya K,Ohta T,Kitagawa H,Kayahara M,Takamura H,Fujimura T,Nishimura G,Shimizu K,Miwa K.Angiotensin II activates MAP kinase and NF-kappaB through angiotensin II type I receptor in human pancreatic cancer cells.Int J Oncol. 2004;25 (4): 849-56
8. Cardone MH,Roy N,Stennicke HR,Salvesen GS,Franke TF,Stanbridge E,Frisch S,Reed JC.Regulation of cell death protease caspase-9 by phosphorylation.Science. 1998;282 (5392): 1318-21
9. George AJ,Thomas WG,Hannan RD.The renin-angiotensin system and cancer: Old dog, new tricks.Nat Rev Cancer. 2010;10 (11): 745-59
10. Li H,Qi Y,Li C,Braseth LN,Gao Y,Shabashvili AE,Katovich MJ,Sumners C.Angiotensin type 2 receptor-mediated apoptosis of human prostate cancer cells.Mol Cancer Ther. 2009;8 (12): 3255-65
11. Danial NN,Korsmeyer SJ.Cell death: Critical control points.Cell. 2004;116 (2): 205-19
12. Tsujimoto Y,Finger LR,Yunis J,Nowell PC,Croce CM.Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation.Science. 1984;226 (4678): 1097-9
13. Reed JC.Bcl-2 family proteins: Regulators of apoptosis and chemoresistance in hematologic malignancies.Semin Hematol. 1997;34 (4): 9-19
14. Kroemer G,Galluzzi L,Brenner C.Mitochondrial membrane permeabilization in cell death.Physiol Rev. 2007;87 (1): 99-163
15. Kirkin V,Joos S,Zornig M.The role of Bcl-2 family members in tumorigenesis.Biochim Biophys Acta. 2004;1644 (2–3): 229-49
16. Fan J,Zhang N,Yin GY,Zhang ZT,Cheng G,Qian WW,Long H,Cai W.Edaravone protects cortical neurons from apoptosis by inhibiting the translocation of BAX and increasing the interaction between 14-3-3 and p-BAD.Int J Neurosci. 2012;122 (11): 665-74
17. Chipuk JE,Green DR.How do BCL-2 proteins induce mitochondrial outer membrane permeabilization?.Trends Cell Biol. 2008;18 (4): 157-64.
18. Ghobrial IM,Witzig TE,Adjei AA.Targeting apoptosis pathways in cancer therapy.Cancer J Clin. 2005;55 (3): 178-94
19. Elmore S.Apoptosis: A review of programmed cell death.Toxicol Pathol. 2007;35 (4): 495-516
20. Funao K,Matsuyama M,Naganuma T,Kawahito Y,Sano H,Nakatani T,Yoshimura R.The cysteiny lLT1 receptor in human renal cell carcinoma.Mol Med Rep. 2008;1 (2): 185-9
21. Funao K,Matsuyama M,Kawahito Y,Sano H,Chargui J,Touraine JL,Nakatani T,Yoshimura R.Telmisartan is a potent target for prevention and treatment in human prostate cancer.Oncol Rep. 2008;20 (2): 295-300
22. Matsuyama M,Funao K,Kuratsukuri K,Tanaka T,Kawahito Y,Sano H,Chargui J,Touraine JL,Yoshimura N,Yoshimura R.Telmisartan inhibits human urological cancer cell growth through early apoptosis.Exp Ther Med. 2010;1 (2): 301-6
23. Papp M,Li XP,Zhuang JJ,Wang RQ,Uhal BD.Angiotensin receptor subtype AT(1) mediates alveolar epithelial cell apoptosis in response to ANG II.Am J Physiol-Lung C. 2002;282 (4): L713-L8
24. Arrieta O,Guevara P,Escobar E,Garcia-Navarrete R,Pineda B,Sotelo J.Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma.Br J Cancer. 2005;92 (7): 1247-52
25. Takahashi S,Uemura H,Seeni A,Tang MX,Komiya M,Long N,Ishiguro H,Kubota Y,Shirai T.Therapeutic targeting of angiotensin II receptor type 1 to regulate androgen receptor in prostate cancer.Prostate. 2012;72 (14): 1559-72
26. Gong QK,Davis M,Chipitsyna G,Yeo CJ,Arafat HA.Blocking angiotensin II type 1 receptor triggers apoptotic cell death in human pancreatic cancer cells.Pancreas. 2010;39 (5): 581-94
27. Ino K,Uehara C,Kikkawa F,Kajiyama H,Shibata K,Suzuki T,Khin EE,Ito M,Takeuchi M,Itakura A,Mizutani S.Enhancement of aminopeptidase A expression during angiotensin II-induced choriocarcinoma cell proliferation through AT(1) receptor involving protein kinase C- and mitogen-activated protein kinase-dependent signaling pathway.J Clin Endocr Metab. 2003;88 (8): 3973-82
28. Muscella A,Greco S,Elia MG,Storelli C,Marsigliante S.Angiotensin II stimulation of Na+/K(+)ATPase activity and cell growth by calcium-independent pathway in MCF-7 breast cancer cells.J Endocrinol. 2002;173 (2): 315-23
29. Suganuma T,Ino K,Shibata K,Kajiyama H,Nagasaka T,Mizutani S,Kikkawa F.Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination.Clin Cancer Res. 2005;11 (7): 2686-94
30. Takahashi T,Taniguchi T,Konishi H,Kikkawa U,Ishikawa Y,Yokoyama M.Activation of Akt protein kinase B after stimulation with angiotensin II in vascular smooth muscle cells.Am J Physiol-Heart C. 1999;276 (6): H1927-H34
31. Cardone M,Roy N,Stennicke H,Stanbridge E,Franke T,Salvesen G,Franke TF,Stanbridge SF,Reed JC.Regulation of cell death protease caspase-9 by Akt-mediated protein phosphorylation.Mol Biol Cell. 1998;9:246-246
32. Datta SR,Dudek H,Tao X,Masters S,Fu HA,Gotoh Y,Gotoh Y,Greenberg ME.Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery.Cell. 1997;91 (2): 231-41
33. Brunet A,Bonni A,Zigmond MJ,Lin MZ,Juo P,Hu LS,Anderson MJ,Arden KC,Blenis J,Greenberg ME.Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor.Cell. 1999;96 (6): 857-68
34. Zhao Y,Chen X,Cai L,Yang Y,Sui G,Wu J.Angiotensin II suppresses adriamycin-induced apoptosis through activation of phosphatidylinositol 3-kinase/Akt signaling in human breast cancer cells.Acta Biochim Biophys Sin. 2008;40 (4): 304-10
35. Bangalore S,Kumar S,Kjeldsen SE,Makani H,Grossman E,Wetterslev J,Gupta AK,Sever PS,Gluud C,Messerli FH.Antihypertensive drugs and risk of cancer: Network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials.Lancet Oncol. 2011;12 (1): 65-82
36. Araujo AA,Lopes de Souza G,Souza TO,de Castro Brito GA,Saboia Aragao K,Xavier de Medeiros CA,Lourenço Y,Alves MSCF,Araújo RF.Olmesartan decreases IL-1beta and TNF-alpha levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitis.Naunyn Schmiedebergs Arch Pharmacol. 2013;386 (10): 875-84
37. Araujo AA,Souza TO,Moura LM,Brito GA,Aragao KS,Araujo LS,Medeiros CA,Alves MS,Araújo RF.Effect of telmisartan on levels of IL-1, TNF-alpha, down-regulated COX-2, MMP-2, MMP-9 and RANKL/RANK in an experimental periodontitis model.J Clin Periodontol. 2013;40 (12): 1104-11